CAS 636-88-4

1,2-Benzenediol, 4-[(1S)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

Description:

1,2-Benzenediol, 4-[(1S)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1), commonly known as a derivative of catecholamine, is a complex organic compound characterized by its dual functional groups and stereochemistry. The presence of the 1,2-benzenediol moiety indicates that it possesses hydroxyl groups attached to a benzene ring, contributing to its potential as a phenolic compound with antioxidant properties. The amino and hydroxyethyl substituents suggest that it may participate in various biochemical interactions, possibly influencing its solubility and reactivity. The (2R,3R)-2,3-dihydroxybutanedioate component indicates the presence of a dicarboxylic acid structure, which can enhance its acidity and reactivity in biological systems. This compound may exhibit chirality due to its stereocenters, leading to different biological activities depending on its configuration. Overall, its unique structure suggests potential applications in pharmaceuticals, biochemistry, and materials science, although specific properties such as solubility, melting point, and reactivity would require empirical data for precise characterization.

Formula: C₈H₁₁NO₃·C₄H₆O₆

InChI: InChI=1S/C8H11NO3.C4H6O6/c9-4-8(12)5-1-2-6(10)7(11)3-5;5-1(3(7)8)2(6)4(9)10/h1-3,8,10-12H,4,9H2;1-2,5-6H,(H,7,8)(H,9,10)/t8-;1-,2-/m11/s1

InChI key: InChIKey=WNPNNLQNNJQYFA-HQWYAZORSA-N

SMILES: [C@H](CN)(O)C1=CC(O)=C(O)C=C1.[C@@H]([C@H](C(O)=O)O)(C(O)=O)O

Synonyms:

• (+)-(S)-Norepinephrine bitartrate
• (+)-Noradrenaline (+)-bitartrate
• (+)-Norepinephrine (+)-bitartrate
• (S)-(+)-Norepinephrine L-bitartrate
• 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt)
• 1,2-Benzenediol, 4-[(1S)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
• 1,2-Benzenediol, 4-[(1S)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
• 4-[(1S)-2-amino-1-hydroxyethyl]benzene-1,2-diol 2,3-dihydroxybutanedioate (1:1)
• <span class="text-smallcaps">D</span>-Norepinephrine bitartrate
• <span class="text-smallcaps">D</span>-Norepinephrine d-bitartrate
• Benzyl alcohol, α-(aminomethyl)-3,4-dihydroxy-, (+)-, tartrate (1:1) (salt)
• D-Norepinephrine hydrogen tartrate salt
• d-Noradrenaline bitartrate

D-(+)-Noradrenaline Tartrate

CAS: 636-88-4

Color and Shape: Neat

Ref: 61-FOR0785.07

(S)-(+)-Norepinephrine L-bitartrate

CAS: 636-88-4

Formula: C₁₂H₁₇NO₉

Purity: 97%

Color and Shape: Solid

Molecular weight: 319.2647

Ref: IN-DA003CI1

D-Norepinephrine Bitartrate

CAS: 636-88-4

Formula: C₈H₁₁NO₃·C₄H₆O₆

Color and Shape: White To Off-White Solid

Molecular weight: 169.18 150.09

Ref: 4Z-N-1711

D-Noradrenaline hydrogen L-tartrate

CAS: 636-88-4

Formula: C₁₂H₁₉NO₁₀

Molecular weight: 337.28

Ref: 7W-GP8773

(+)-Noradrenaline Bitartrate

CAS: 636-88-4

Formula: C₈H₁₁NO₃·C₄H₆O₆

Color and Shape: White To Off-White

Molecular weight: 319.26

Ref: TR-N661025

(+)-Noradrenaline-d5 Bitartrate

Controlled Product

CAS: 636-88-4

Stability Hygroscopic
Applications (+)-Noradrenaline-d5 Bitartrate is a labeled analogue of (+)-Noradrenaline Bitartrate (N661025), an agonist at α1- and α2-adrenoreceptors.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Leedham, J.A., Pennefather, J.N., J. Auton. Pharmacol., 6, 39 (1986)

Formula: C₁₂H₁₂D₅NO₉

Color and Shape: Neat

Molecular weight: 324.3

Ref: TR-N661028

(S)-(+)-Norepinephrine L-bitartrate

CAS: 636-88-4

Purity: 97%

Molecular weight: 319.09

Ref: 10-F568476

4-[(1S)-2-Amino-1-Hydroxy-Ethyl]Benzene-1,2-Diol

CAS: 636-88-4

4-[(1S)-2-Amino-1-Hydroxy-Ethyl]Benzene-1,2-Diol is an organic compound with the chemical formula C6H8N2O3. It is a monohydrate of 4-(hydroxymethyl)benzene-1,2-diol. This compound is available as a white powder and has been used in the past for research purposes. 4-[(1S)-2-Amino-1-Hydroxy-Ethyl]Benzene-1,2-Diol has shown to be a potent blocker of cardiac Na+ channels and interacts with metoprolol to produce additive effects on heart rate and cardiac output. This drug also has properties that are consistent with being an orthorhombic crystal form with an isopropyl group on one end. The molecular weight calculated by infrared spectroscopy is found to be 217.06 g/mol.

Formula: C₁₂H₁₇NO₉

Purity: Min. 95%

Molecular weight: 319.27 g/mol

Ref: 3D-FA146097